Table 2.
Summary of in vitro PsV neutralization titers in L1 PBNA.
| Neutralization titers | ||||||||
|---|---|---|---|---|---|---|---|---|
| HPV-11 | HPV-16 | HPV-18 | HPV-58 | |||||
| PB | FB | PB | FB | PB | FB | PB | FB | |
| SAC 108-120 | NN | NN | NN | NN | NN | 200 | NN | NN |
| SAC 65-81 | NN | NN | NN | NN | NN | 200 | NN | 50 |
| SAC 56-81 | NN | NN | NN | NN | NN | 200 | NN | NN |
| SAC 17-36 | NN | NN | NN | NN | NN | NN | NN | NN |
| SAE 65-81 | NN | 100 | NN | 50 | NN | 50 | NN | NN |
| hL1 | NN | NN | NN | ≥6,400 | NN | NN | NN | NN |
| Empty vector | NN | NN | NN | NN | NN | NN | NN | NN |
| PBS | NN | NN | NN | NN | NN | NN | NN | NN |
Assays were performed in duplicate due to limited blood volume.
NN – No neutralization.